medicine

grapheneGraphene-lined Clothing Could Prevent Mosquito Bites

Graphene sheets can block the signals mosquitos use to identify a blood meal, potentially enabling a new chemical-free approach to mosquito bite prevention. Researchers showed that multilayer graphene can provide a two-fold defense against mosquito bites. The ultra-thin yet strong …

antiagingUnderestimating Life Expectancy Improvements on Insurance Policies

General Electric has recently been accused of accounting fraud for not properly reporting the cost of providing Long Term Care to old people on insurance policies sold many years ago. All of the insurance companies that sold long-term care insurance …

medicineHuman Longevity’s David Karow Says to Measure What Matters for Your Health

Health Nucleus offers a personalized health assessment that integrates imaging and genomics to generate a more complete picture of your current state of health and future risks. A third of the risk of Alzheimers and Dementia are modifiable. Brian Wang …

futureDaniel Kraft Surveys State of Medicine

Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as Faculty Chair for Medicine & Neuroscience at Singularity University since …

businessWhat is Hot in Disruptive Technology? #suglobalsummit

Insights from the Frontlines of VC: Scott Barclay, Partner, Data Collective; Amy LaMeyer, WXR Fund, Will Weisman, Executive Director, Summits, Singularity University, Neal Bhadkamkar; Bold Ventures Nishita Henry, Chief Innovation Officer, Deloitte, moderator Scott Barclay feels we are close to …

antiagingVenture Capital Investment in Disruptive Technology #suglobalsummit

A Bold Perspective on Investing: Neal Bhadkamkar, General Partner, Bold Capital Partners Neal brings more than 30 years of investment and start-up experience as General Partner of BOLD. Previously, Neal was co-founder and General Partner of Monitor Ventures (an early …

diseaseEbola Vaccine and New Ebola Drugs are Effective

An Ebola vaccine (rVSV-ZEBOV-GP Ebola vaccine) tested in Africa is 97.5% effective. Only 8.8% (60/679) of the vaccinated rings reported Ebola cases, and only 2.2% (15/679) reported Ebola cases 10 days or more after vaccination.The majority of cases among vaccinated …

crisprMany CRISPR Gene Editing Clinical Trials Underway

Human clinical trials are using CRISPR/Cas9 to combat cancer and blood disorders. In these tests, researchers remove some of a person’s cells, edit the DNA and then inject the cells back in, now hopefully armed to fight disease. Researchers are …